title: Supplementary chromium(III) propionate complex does not protect against insulin resistance in high-fat-fed rats.
abstract: Improper eating habits such as high-fat or high-carbohydrate diets are responsible for metabolic changes resulting in impaired glucose tolerance, hyperinsulinemia, insulin resistance, and ultimately diabetes. Although the essentiality of trivalent chromium for humans has been recently questioned by researchers, pharmacological dosages of this element can improve insulin sensitivity in experimental animals and diabetic subjects. The aim of the study was to assess the preventive potential of the supplementary chromium(III) propionate complex (CrProp) in rats fed a high-fat diet. The experiment was conducted on 32 male Wistar rats divided into four groups and fed the following diets: the control (C, AIN-93G), high-fat diets (HF, 40% energy from fat), and a high-fat diet supplemented with CrProp at dosages of 10 and 50 mg Cr/kg diet (HF + Cr10 and HF + Cr50, respectively). After 8 weeks, high-fat feeding led to an increased body mass, hyperinsulinemia, insulin resistance, a decreased serum urea concentration, accumulation of lipid droplets in hepatocytes, and increased renal Fe and splenic Cu contents. Supplementary CrProp in both dosages did not alleviate these changes but increased renal Cr content and normalized splenic Cu content in high-fat-fed rats. Supplementary CrProp does not prevent the development of insulin resistance in rats fed a high-fat diet.
authors.affiliation: Department of Human Nutrition and Hygiene, Poznan University of Life Sciences, Wojska Polskiego 31, 60-624, Poznan, Poland, ekrol@up.poznan.pl.
authors.forename: Ewelina
authors.initials: E
authors.lastname: Król
authors.forename: Zbigniew
authors.initials: Z
authors.lastname: Krejpcio
authors.forename: Katarzyna
authors.initials: K
authors.lastname: Iwanik
mesh_terms: D000821:Animal Feed; D000818:Animals; D001786:Blood Glucose / Q000032:analysis; D002857:Chromium / Q000008:administration & dosage / Q000494:pharmacology*; D059305:Diet, High-Fat / Q000009:adverse effects*; D019587:Dietary Supplements; D007328:Insulin / Q000097:blood; D007333:Insulin Resistance; D007668:Kidney / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D008055:Lipids / Q000097:blood; D008099:Liver / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D008297:Male; D011422:Propionates / Q000008:administration & dosage / Q000494:pharmacology*; D051381:Rats; D017208:Rats, Wistar; D014131:Trace Elements / Q000378:metabolism
chemical_list: D001786:Blood Glucose; D007328:Insulin; D008055:Lipids; D011422:Propionates; D014131:Trace Elements; D002857:Chromium; C029658:propionic acid